Study guide
9.1 Aortic Regurgitation Mechanisms and Integrated Severity
CCI Registered Cardiac Sonographer RCS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: RCS Orientation and Clinical Context
1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context
2 Chapter 2: Orders, Safety, and Patient Preparation
2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare
3 Chapter 3: Reporting and 2-D TTE Foundations
3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA
4 Chapter 4: M-Mode and Doppler Acquisition
4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition
5 Chapter 5: Advanced Doppler and Contrast
5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts
6 Chapter 6: Stress Echocardiography
6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation
7 Chapter 7: TEE, Strain, and 3-D TEE
7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts
8 Chapter 8: 3-D TTE and the Aortic Valve
8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States
9 Chapter 9: Aortic Regurgitation and Mitral Structure
9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability
10 Chapter 10: Mitral and Tricuspid Valve Findings
10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment
11 Chapter 11: Right-Sided Valve Disease
11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment
12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves
12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch
13 Chapter 13: Endocarditis and Cardiac Chambers
13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function
14 Chapter 14: Cardiomyopathy Phenotypes and Diastology
14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls
15 Chapter 15: Systolic Function and Ischemia
15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications
16 Chapter 16: Pericardium and Great Vessels
16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation
17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition
17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues
18 Chapter 18: Devices, Strain, and Hemodynamics
18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts
19 Chapter 19: Infiltrative Disease and Physics Foundations
19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing
20 Chapter 20: Resolution and Doppler Optimization
20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain
21 Chapter 21: 2-D, 3-D, and Contrast Optimization
21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts
9.1 Aortic Regurgitation Mechanisms and Integrated Severity
Key Takeaways Explain This Topic AI
AR mechanism may reflect normal cusp motion with root dilation or perforation, excessive cusp motion from prolapse, or restricted abnormal cusps.
Severity integrates valve and root anatomy, vena contracta, central jet width, CW decay, aortic flow reversal, quantitative measures, and LV response.
Severe chronic AR is supported by vena contracta >0.6 cm, central jet width ≥65% of LVOT, regurgitant volume ≥60 mL, regurgitant fraction ≥50%, or EROA ≥0.30 cm² when technically valid.
Acute AR, eccentric jets, loading conditions, rhythm, aortic compliance, and measurement geometry can create discordance that requires explanation rather than numeric averaging.
Last updated: July 2026
Start with the valve, root, and mechanism
Aortic regurgitation, or AR, is diastolic flow from the aorta into the LV caused by failure of cusp coaptation. The lesion may arise from the cusps, the aortic root, or both. Begin with parasternal long- and short-axis sweeps: identify cusp number and morphology, coaptation level, thickening, calcification, prolapse, flail tissue, perforation, vegetation, and a dissection flap. Measure the annulus, sinuses of Valsalva, sinotubular junction, and ascending aorta with the current laboratory method. A bicuspid valve can leak through cusp prolapse or restriction and may coexist with aortopathy; a tricuspid valve can leak despite normal cusp tissue when the root enlarges.
A functional classification links motion to cause and potential repair strategy. It describes dysfunction, not severity.
Functional pattern Motion and mechanism Examples or clues
Type I Cusp motion is normal, but coaptation fails because the root or annulus is enlarged or a cusp has a perforation Dilated sinotubular junction, sinuses, ventriculoarterial junction, endocarditic perforation
Type II Excessive cusp motion places a free margin below the expected coaptation level in diastole Cusp prolapse, excessive tissue, commissural disruption, flail segment
Type III Cusp opening and/or closure is restricted by abnormal tissue Bicuspid morphology, rheumatic fibrosis, degenerative calcification, radiation injury
Acute AR from endocarditis, dissection, trauma, or sudden cusp disruption is physiologically different from chronic AR. The acutely overloaded LV may remain normal in size while its diastolic pressure rises sharply. Premature mitral closure, diastolic MR, tachycardia, a short low-velocity AR signal, hypotension, or rapid deterioration can be critical clues. Chronic AR allows eccentric LV remodeling and a larger stroke volume; serial LV size and systolic function then become important evidence of the volume burden. A normal-sized LV argues against chronic severe AR only when body size, duration, and other causes are considered.
Acquire each component of the regurgitant signal
Record blood pressure, heart rate, rhythm, height, weight, and body surface area. Color Doppler should show flow convergence above the valve, the vena contracta through the orifice, and jet direction and width within the LVOT. Use multiple long-axis windows and short-axis sweeps. Measure vena contracta perpendicular to the jet in a zoomed, well-resolved view. The central jet-width/LVOT-width ratio is measured just apical to the valve in parasternal long axis; it is not validated for an eccentric jet that is cut obliquely or entrained along a wall. Jet area alone is especially dependent on gain, Nyquist scale, driving pressure, receiving-chamber constraints, and eccentricity.
Obtain a complete CW envelope through the AR jet. Density supports the amount of regurgitant flow, while deceleration reflects pressure equalization between aorta and LV. Record PW Doppler in the proximal descending aorta and, when useful, abdominal aorta with the beam aligned to flow. Brief early-diastolic reversal can be normal; prominent holodiastolic reversal is a specific supportive sign of severe AR, although aortic compliance and peripheral resistance affect it. Quantitative methods can derive regurgitant volume, regurgitant fraction, and effective regurgitant orifice area, but each input must come from compatible beats and correctly placed measurements.
Integrate severity instead of voting by one number
Parameter in chronic AR Mild range or pattern Severe range or pattern Major limitation
Valve and LV Small lesion; LV usually normal Flail or wide coaptation defect; LV usually dilated if chronic Acute severe AR may have no time to dilate
- Vena contracta width <0.3 cm >0.6 cm Multiple or irregular orifices and lateral resolution
- Central jet width/LVOT width <25% ≥65% Do not apply to eccentric jets
CW pressure half-time >500 ms <200 ms LV compliance, LV diastolic pressure, aortic pressure, and therapy alter decay
Descending-aortic PW Brief early reversal Prominent holodiastolic reversal Aortic compliance and peripheral resistance
Regurgitant volume <30 mL/beat ≥60 mL/beat Diameter error is squared; other valve lesions invalidate some volumetric comparisons
- Regurgitant fraction <30% ≥50% Requires accurate forward and total stroke volumes
- EROA <0.10 cm² ≥0.30 cm² PISA may be nonhemispheric, eccentric, dynamic, or difficult to measure
Intermediate values define a spectrum, not a shortcut to averaging categories. Concordant mechanism, structural findings, color, CW, aortic flow reversal, quantitation, and chamber response give confidence. Vena contracta and PISA should not be measured from a blooming or poorly resolved jet. For PISA, optimize baseline shift and measure the aliasing radius at the specified diastolic frame; multiple jets, a noncircular orifice, and an incomplete CW envelope can make EROA and regurgitant volume unreliable. Volumetric AR calculations are invalid when the comparison stroke volume is altered by significant regurgitation at another valve.
Loading and rhythm matter. Higher systemic pressure can increase the diastolic driving force and regurgitant burden, while elevated LV diastolic pressure can shorten pressure half-time without a larger anatomic orifice. Bradycardia lengthens the time available for regurgitation; ectopy and atrial fibrillation make beat selection important. Compare representative beats and do not call a serial change biologic until blood pressure, rhythm, settings, and measurement quality have been reviewed.
When findings disagree, identify which measurement failed and which physiology explains the conflict. An eccentric jet with a small color area but a wide vena contracta, dense CW signal, holodiastolic reversal, and LV volume overload should not be downgraded by jet area. Conversely, a short pressure half-time in a stiff, high-pressure LV cannot establish severe AR by itself. Report the mechanism, severity evidence, LV response, aortic dimensions, hemodynamics, and limitations. TEE clarifies valve and root anatomy when TTE is inadequate; CMR can quantify AR and remodeling when echocardiographic or clinical data remain discordant.
Acute severe AR may look deceptively small
A normal LV size, short color-jet duration, or low AR velocity does not exclude acute severe AR. Integrate the clinical setting, cusp or aortic pathology, premature mitral closure, pressure equalization, and urgent team communication.